VVIPS Gudlavalleru

FORMULATION AND EVALUATION OF PRAMIPEXOLE DIHYDEOCHLORIDE MONOHYDRATE EXTENDED RELEASE TABLETS

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT OF MULTIPATRICULATE SYSTEM OF MEBEVERINE HYDROCHORIDE FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF ORAL DISINTEGRATION TABLETS OF ZIPRASIDONE HCI BY USING SOLID DISPERSION

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND INVITRO EVALUATION OF THEOPHYLLINE BILAYERED TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF DROTAVERIN HYDROCHLORIDE ORODISPERSABLE TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF METFORMIN EXTENDED RELEASE TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND INVITRO EVALUATION OF GASTRO RETENTIVE LISINOPRIL MATRIX TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND IN-VITRO EVALUATION OF FLOATING TABLETS OF HYDROCHLOROTHIAZIDE BY USING VARIOUS POLYMERS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF ORAL DISINTEGRATING TABLETS OF LOSARTAN POTASSIUM

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF BI-LAYERED TABLETS OF ZIDOVUDINE AND ACYCLOVIR

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF ACECLOFENAC SUSTAINED RELEASE TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING DOSAGE FORMS OF LAMIVUDINE

V. V. Institute of Pharmaceutical Sciences

DESIGN AND IN VITRO EVALUATION OF TOLFENAMIC ACID CONTROLLED RELEASE FORMULATIONS

V. V. Institute of Pharmaceutical Sciences

OPTIMIZATION AND IN-VITRO CHARACTERIZATION OF ENTERIC COATED TABLETS OF RABEPRAZOLE SODIUM

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERES OF STAVUDINE

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF SUSTAINED RELEASE BILAYER TABLETS OF LOSARTAN POTASSIUM

V. V. Institute of Pharmaceutical Sciences

1. METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ALBENDAZOLE AND PRAZIQUENTEL BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF IMATINIB AND ITS METABOLITE DESMETHYLIMATINIB IN HUMAN PLASMA USING LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC DETECTION

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT & EVALUATION OF GLIBENCLAMIDE FLOATING TABLETS WITH FIXED RELEASE

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND INVITRO EVALUATION OF EFAVIRENZ SUSTAIN RELEASE TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF FRUSEMIDE FLOATING TABLETS USING NATURAL POLYMERS

V. V. Institute of Pharmaceutical Sciences

SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE DRUG BY HOT MELT EXTRUSION TECHNIQUE

V. V. Institute of Pharmaceutical Sciences

PREPARATION & EVALUATION OF EMPAGLIFLOZIN TABLETS

V. V. Institute of Pharmaceutical Sciences

INVITRO EVALUATION OF EPLERENONE CONTROLLED RELEASE TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF IVABRADINE FLOATING TABLETS USING SYNTHETIC POLYMERS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF FLOATING MATRIX TABLETS OF ZIPRASIDONE HYDROCHLORIDE

V. V. Institute of Pharmaceutical Sciences

ENHANCEMENT OF GLICLAZIDE SOLUBILITY AND DISSOLUTION BY SOLID DISPERSION TECHNIQUE

V. V. Institute of Pharmaceutical Sciences

PREPARATION, EVALUATION AND CHARACTERIZATION OF SUSTAINED FLOATING TABLETS OF VILDAGLIPTIN

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND INVITRO EVALUATION OF CIMETIDINE FLOATING TABLETS USING NATURAL POLYMERS

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND EVALUATION OF BUCCAL ADHESIVE CONTROLLED RELEASE TABLETS OF LERCANIDIPINE

V. V. Institute of Pharmaceutical Sciences

PREPARATION AND CHARACTERIZATION OF ORAL DISSOLVING FILMS OF ONDANSETRON

V. V. Institute of Pharmaceutical Sciences

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF MOXINIDINE AND HYDROCHLORTHIAZIDE IN BULK AND TABLET DOSAGE FORM BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF NOVEL STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF EPALRESTAT AND PREGABILIN

V. V. Institute of Pharmaceutical Sciences

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LINAGLIPTIN AND EMPAGLIFLOZIN

V. V. Institute of Pharmaceutical Sciences

BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CANDESARTAN IN HUMAN PLASMA BY USING LC MS/MS

V. V. Institute of Pharmaceutical Sciences

NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PROGUANIL AND ATOVAQUONE

V. V. Institute of Pharmaceutical Sciences

BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DESLORATIDINE IN HUMAN PLASMA BY USING LC MS/MS

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AMOXYCILLIN AND CLAVULANIC ACID IN PHARMACEUTICAL DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF METFORMIN AND GLIPIZIDE

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF QUANTIFICATION OF MEDROXYPROGESTERONE IN HUMAN PLASMA BY USING LC MS/MS

V. V. Institute of Pharmaceutical Sciences

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF PANTAPRAZOLE AND ONDANSETRON BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

VALIDATED RP-HPLC METHOD FOR ESTIMATION OF CARISOPRODOL AND IBUPROFEN IN TABLET DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF HYDROCHLORTHIAZIDE AND MOEXIPIRIL IN BULK AND DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ANALYSIS OF CEPHALEXIN AND BROMHEXINE IN CAPSULE DOSAGE FORMS

V. V. Institute of Pharmaceutical Sciences

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR DETERMINATION OF CEFIXIME AND ACETYL CYSTEINE IN PURE AND DOSAGE FORMS

V. V. Institute of Pharmaceutical Sciences

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF OXYCODONE AND PARACETAMOL IN BULK AND PHARMACEUTICAL FORMULATION USING THE RP-HPLC METHOD

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF DICLOFENAC POTASSIUM IMMEDIATE RELEASE FILM COATED TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND DEVELOPMENT OF GRANULES FOR ORAL SUSPENSION OF FIXED DOSE COMBINATION OF ANALGESIC ACTIVITIES

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF METOPROLOL SUCCINATE BUCCAL ADHESIVE TABLETS USING NATURAL POLYMERS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND DEVELOPMENT OF TRIPLE COMBINATION OF BILAYER ANTI-RETROVIRAL TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND INVTRO EVALUATION OF MULTIPARTICULATES FOR COLON TARGETING

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF BILAYERED TABLETS OF METFORMIN HCL SUSTAIN RELEASE AND GLIMEPIRIDE IMMEDIATE RELEASE

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND VELPATASVIR IN TABLET DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

BIOANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DAPAGLIFLOZIN IN HUMAN PLASMA BY USING LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC DETECTION

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF MEROPENEM AND VABORBACTUM IN PHARMACEUTICAL DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF FLUVOXAMINE MALEATE IN HUMAN PLASMA BY USING LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC DETECTION

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF VELPATASVIR, SOFOSBUVIR AND VOXILAPREVIR IN TABLET DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF GLECAPREVIR AND PIBRENTASVIR BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE PELLETS BY AN ANTICOAGULANT PRODRUG

V. V. Institute of Pharmaceutical Sciences

ENHANCEMENT OF SOLUBILITY OF POORLY WATER SOLUBLE DRUG USING HOT MELT EXTRUSION METHOD

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND INVITRO EVALUTION OF SATRANIDAZOLE MULTIPARTICULATE FOR COLON TARGETING

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF METOPROLOL BUCCAL ADHESIVE TABLETS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF ESOMEPRAZOLE MAGNESIUM TRIHYDRATE DELAYED RELEASE PELLETS

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND EVALUATION OF PROTON PUMP INHIBITOR AS MUPS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF TOLTERODINE TARTRATE SUSTAINED RELEASE PELLETS BY USING EXTRUSION-SPHERONIZATION TECHNIQUE

V. V. Institute of Pharmaceutical Sciences

RP-HPLC METHOD DEVELOPMENT & VALIDATION OF CLEANING PROCEDURE FOR RANOLAZINE RESIDUAL DETERMINATION IN TABLET MANUFACTURING

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR THE SIMULTANEOUS QUANTITATION OF RAMIPRIL AND ITS METABOLITE RAMIPRILAT IN HUMAN K3EDTA PLASMA BY USING LC-MS/MS

V. V. Institute of Pharmaceutical Sciences

BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ALVERINE AND ITS 4-HYDROXY ALVERINE IN HUMAN PLASMA USING LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC DETECTION

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DETERMINATION OF PROPRANOLOL HYDROCHLORIDE RELATED SUBSTANCES IN EXTENDED RELEASE CAPSULES

V. V. Institute of Pharmaceutical Sciences

BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS QUANTIFICATION OF DOLUTEGRAVIR AND LAMIVUDINE IN PRESENCE OF TENOFOVIR IN HUMAN K?EDTA PLASMA BY USING LC-MS/MS

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF BIOANALYTICAL METHOD FOR THE QUANTIFICATION OF TENOFOVIR IN HUMAN PLASMA BY USING LC-MS/MS

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF NALTREXONE HCl AND BUPROPION HCl BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF METFORMIN AND ERTUGLIFLOZIN IN PURE AND TABLET DOSAGE FORM BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF CONTROLLED DRUG DELIVERY OF DICLOFENAC SODIUM IMMEDIATE RELEASE FILM COATED TABLETS

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND IN VITRO EVALUATION OF BUCCAL ADHESIVE TABLET OF METOPROLOL SUCCINATE

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF GRDDS OF REPAGLINIDE

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF NOVEL DRUG DELIVERY SYSTEM OF EUGENOL

V. V. Institute of Pharmaceutical Sciences

DESIGN AND DEVELOPMENT OF TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF COLON TARGETED SATRANIDAZOLE MICROSPHERES

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF FLOATING MATRIX TABLETS OF AN ANTIPSYCHOTIC DRUG

V. V. Institute of Pharmaceutical Sciences

FORMULATION, OPTIMIZATION, CHARACTERIZATION AND EVALUATION OF BILAYERED TABLETS OF ANTIHYPERTENSIVE DRUGS

V. V. Institute of Pharmaceutical Sciences

FORMULATION AND EVALUATION OF BISOPROLOL ORAL BUCCAL ADHESIVE TABLETS BY USING BOTH NATURAL AND SYNTHETIC POLYMERS

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF METHYLCOBALAMIN, EPALRESTAT AND PREGABALIN IN PURE AND TABLET DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

RP-HPLC METHOD DEVELOPMNT & VALIDATION OF CLEANING PROCEDURE FOR PYRIDOXINE HYDROCHLORIDE RESIDUAL DETERMINATION IN TABLET MANUFACTURING

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS QUANTITATION OF ITRACONAZOLE AND TERBINAFINE IN PURE SUBSTANCE AND PHARMACEUTICAL FORMULATION

V. V. Institute of Pharmaceutical Sciences

METHOD VALIDATION AND AUTOMATION OF RELATED SUBSTANCES ANALYSIS OF SITAGLIPTIN API BY USING LIMS SOFTWARE

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING METHOD FOR DETERMINATIONOF CITALOPRAM IN CITALOPRAM HYDROBROMIDE TABLETS BY RP-HPLC

V. V. Institute of Pharmaceutical Sciences

RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF CINITAPRIDE AND PANTOPRAZOLE IN BULK AND PHARMACEUTICAL DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF PITAVASTATIN AND EZETIMIBE IN BULK AND BRANDED FORMULATION

V. V. Institute of Pharmaceutical Sciences

SIMULTANEOUS ESTIMATION OF ANTIRETROVIRAL DRUGS LOPINAVIR AND RITONAVIR BY VALIDATED RP-HPLC AND UV- SPECTROPHOTOMETRIC METHODS IN PHARMACEUTICAL DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ALISKIREN AND AMLODIPINE IN PURE AND TABLET DOSAGE FORM BY USING RP-HPLC

V. V. Institute of Pharmaceutical Sciences

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF BISOPROLOL AND CILINIDIPINE IN BULK AND PHARMACEUTICAL DOSAGE FORM

V. V. Institute of Pharmaceutical Sciences

METHOD VALIDATION AND AUTOMATION OF ANALYTICAL METHOD FOR QUANTIFICATION OF RELATED SUBSTANCES IN ESOMEPRAZOLE API BY USING LIMS SOFTWARE

V. V. Institute of Pharmaceutical Sciences

IN-HOUSE R&D PROJECTS